- Home
- / Caris Life Sciences
Caris Life Sciences
Market Valuation
$7.8 B
2021-05-11
Total Funding
$1.1 B
Caris Life Sciences Summary
Company Summary
- Overview
- Caris Life Sciences is a molecular science company. It offers Caris Molecular Intelligence (CMI), a product that provides oncologists with treatment options to personalize cancer care. The company also develops its ADAPT Biotargeting System, a profiling platform with applications across therapy development, drug delivery, advanced diagnostics, and disease monitoring. 033904227
- Type
- Private
- Status
- Active
- Founded
- 1996
- HQ
- Irving, TX, US | view all locations
- Cybersecurity rating
Table of Contents
Key People
Chadi Nabhan, Chairman, Precision Oncology Alliance
David Spetzler, President, Chief Scientific Officer
Stephanie Thomas, Executive Vice President, Chief of Staff, Office of the CEO
Operating MetricsView all
Products and Services
4
Feb, 2023
Locations
6
Feb, 2023
Expertise Areas
8
Feb, 2023
LocationsView all
11 locations detected
Irving, TX HQ
United States
750 W John Carpenter Fwy #800 TX 75039
Denver, CO
United States
1875 Lawrence St #1100
Irving, TX
United States
3600 W Royal Ln
New York, NY
United States
510 Madison Ave
Phoenix, AZ
United States
4025 E Cotton Center Blvd
Phoenix, AZ
United States
4415 E Cotton Center Blvd #100